The global Positron Emission Tomography (PET) market is set to witness a growth rate of 5% in the next 5 years. Growing prevalence of chronic diseases; technological advancements in ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering ...

Researchers, led by Dr Rafael T. M. de Rosales and Dr Graeme Stasiuk, have been awarded £10 million in funding from the ...

This early prototype was just 10 cm wide, but Lawrence’s innovation was so impactful that it earned him the 1939 Nobel Prize ...

Learn how PET study shows safe, targeted brain delivery of intranasal insulin, a critical step for future Alzheimer’s ...

With multiple clinical trials and approval applications in train, nuclear medicine superstar Telix Pharmaceuticals (ASX:TLX) ...

HealthDay News — Intranasal administration of [ 68 Ga]Ga-NOTA-insulin is safe and delivers insulin to multiple brain regions, according to a study published online July 23 in Alzheimer’s & Dementia: ...

More than 500 nuclear medicine facilities are available in the government and private sectors, Union Minister of State for ...

Traditionally, the diagnosis of Alzheimer’s disease has been based on informant interviews and clinical assessments of memory, cognition, behaviour, and mood. To increase diagnostic confidence, ...

Are men’s and women’s hearts that different? Yes, they are, and knowing those differences could save a woman’s life.

The company presented new data from its Alzheimer’s disease research efforts across its diagnostics and pharmaceutical ...